Works by Seung-Hyun Nam

Results: 20

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 27, doi. 10.1007/s00280-008-0847-y

By:

Sun Jin Sym;
Dae Ho Lee;
Hye Jin Kang;
Seung Hyun Nam;
Ho Young Kim;
Seok Jin Kim;
Hyeon Seok Eom;
Won Seog Kim;
Cheolwon Suh

Publication type:

Article

Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1355, doi. 10.4143/crt.2023.271

By:

Yu Ri Kim;
Jin Seok Kim;
Won Seog Kim;
Hyeon Seok Eom;
Deok-Hwan Yang;
Sung Hwa Bae;
Hyo Jung Kim;
Jae Hoon Lee;
Suk-Joong Oh;
Sung-Soo Yoon;
Jae-Yong Kwak;
Chul Won Choi;
Min Kyoung Kim;
Sung Young Oh;
Hye Jin Kang;
Seung Hyun Nam;
Hyeok Shim;
Joon Seong Park;
Yeung-Chul Mun;
Cheolwon Suh

Publication type:

Article

Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01.

Published in:

Cancer Research & Treatment, 2018, v. 50, n. 2, p. 590, doi. 10.4143/crt.2017.172

By:

Jung Hye Choi;
Tae Min Kim;
Hyo Jung Kim;
Sung Ae Koh;
Yeung-Chul Mun;
Hye Jin Kang;
Yun Hwa Jung;
Hyeok Shim;
So Young Chong;
Der-Sheng Sun;
Soonil Lee;
Byeong Bae Park;
Jung Hye Kwon;
Seung-Hyun Nam;
Jun Ho Yi;
Young Jin Yuh;
Jong-Youl Jin;
Jae Joon Han;
Seok-Hyun Kim

Publication type:

Article

Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Tissue Type Involving the Dura.

Published in:

2016

By:

Joon Young Choi;
Ji Hwan Chung;
Young Jun Park;
Geun Yong Jung;
Tae Wook Yoon;
Yoon Jung Kim;
Tae kyu Lim;
Bong Seog Kim;
Seung-Hyun Nam

Publication type:

Case Study

Effect of Dose Escalation with Single Opioid, Fentanyl Matrix in Patients Not Controlling Cancer Pain: A Multicenter, Prospective, Observational Study in Korea.

Published in:

Cancer Research & Treatment, 2013, v. 45, n. 4, p. 263, doi. 10.4143/crt.2013.45.4.263

By:

Sung Ae Koh;
Kyung Hee Lee;
Mi Jung Kim;
Kyu Taek Lee;
Seung Woo Park;
Seung Hyun Nam;
Hun Mo Ryoo

Publication type:

Article

A Phase II Study of Single-Agent Gemcitabine as a Second-Line Treatment in Advanced Non-Small Cell Lung Cancer.

Published in:

Japanese Journal of Clinical Oncology, 2006, v. 36, n. 1, p. 50, doi. 10.1093/jjco/hyi213

By:

Cho, Keun-Hyok;
Song, Young-Bong;
Choi, Ik-Sung;
Cho, Eun-Hee;
Choi, Jae-Won;
Ahn, Young Mi;
Roh, Yong Ho;
Nam, Seung-Hyun;
Kim, Bong-Seog

Publication type:

Article

Comparison of Medical Expenditure According to Types of Hospice Care in Patients With Terminal Cancer.

Published in:

2013

By:

Lim, Taekyu;
Nam, Seung-Hyun;
Kim, Mi Sun;
Yoon, Kyung Sook;
Kim, Bong-Seog

Publication type:

Journal Article

Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report.

Published in:

Supportive Care in Cancer, 2013, v. 21, n. 4, p. 1175, doi. 10.1007/s00520-012-1646-x

By:

Kwon, Jung;
Oh, Sung;
Chisholm, Gary;
Lee, Jung-Ae;
Lee, Jae;
Park, Keon;
Nam, Seung-Hyun;
Song, Hun;
Lee, Keehyun;
Zang, Dae;
Kim, Ho;
Choi, Dae;
Kim, Hyo;
Kim, Jung;
Jung, Joo;
Jang, Geundoo;
Kim, Hyeong;
Won, Ji;
Bruera, Eduardo

Publication type:

Article

A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatmentnaïve, high-risk essential thrombocythemia as a primary treatment.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.989984

By:

Ja Min Byun;
Ho Young Kim;
Seung-Hyun Nam;
Ho-Jin Shin;
Seulki Song;
Jinny Park;
Sang Hoon Han;
Yong Park;
Young Jin Yuh;
Yeung-Chul Mun;
Young Rok Do;
Sang Kyun Sohn;
Sung Hwa Bae;
Dong-Yeop Shin;
Sung-Soo Yoon

Publication type:

Article

Contribution of the Sub‐Surface to Electrocatalytic Activity in Atomically Precise La0.7Sr0.3MnO3 Heterostructures.

Published in:

Small, 2021, v. 17, n. 49, p. 1, doi. 10.1002/smll.202103632

By:

Lee, Jegon;
Adiga, Prajwal;
Lee, Sang A;
Nam, Seung Hyun;
Ju, Hyeon‐Ah;
Jung, Min‐Hyoung;
Jeong, Hu Young;
Kim, Young‐Min;
Wong, Cindy;
Elzein, Radwan;
Addou, Rafik;
Stoerzinger, Kelsey A.;
Choi, Woo Seok

Publication type:

Article

The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.

Published in:

Acta Haematologica, 2018, v. 140, n. 3, p. 146, doi. 10.1159/000490488

By:

Lee, Gyeong-Won;
Park, Sung Woo;
Go, Se-Il;
Kim, Hoon-Gu;
Kim, Min Kyoung;
Min, Chang-Ki;
Kwak, Jae-Yong;
Bae, Sang-Byung;
Yoon, Sung-Soo;
Lee, Je-Jung;
Kim, Ki Hwan;
Nam, Seung-Hyun;
Mun, Yeung-Chul;
Kim, Hyo Jung;
Bae, Sung Hwa;
Shin, Ho-Jin;
Lee, Jung-Hee;
Park, Joon Seong;
Jeong, Seong Hyun;
Lee, Mark Hong

Publication type:

Article

Early Imatinib Mesylate-Induced Hepatotoxicity in Chronic Myelogenous Leukaemia.

Published in:

Acta Haematologica, 2007, v. 118, n. 4, p. 205, doi. 10.1159/000111092

By:

Jee Hyun Kong;
Seung-Hyun Yoo;
Kyoung Eun Lee;
Seung Hyun Nam;
Jung Mi Kwon;
Sang Min Lee;
Hye Jung Chang;
Moon Young Choi;
Min Sun Cho;
Yeung-Chul Mun;
Eunmi Nam;
Soon Nam Lee;
Chu-Myong Seong

Publication type:

Article

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Published in:

2013

By:

Kang, Hye Jin;
Lee, Seung-Sook;
Byun, Byung Hyun;
Kim, Kyeong Min;
Lim, Ilhan;
Choi, Chang Woon;
Suh, Cheolwon;
Kim, Won Seog;
Nam, Seung-Hyun;
Lee, Soon Il;
Eom, Hyeon Seok;
Shin, Dong-Yeop;
Lim, Sang Moo

Publication type:

journal article

Repeated radioimmunotherapy with I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 945, doi. 10.1007/s00280-013-2087-z

By:

Kang, Hye;
Lee, Seung-Sook;
Byun, Byung;
Kim, Kyeong;
Lim, Ilhan;
Choi, Chang;
Suh, Cheolwon;
Kim, Won;
Nam, Seung-Hyun;
Lee, Soon;
Eom, Hyeon;
Shin, Dong-Yeop;
Lim, Sang

Publication type:

Article

A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 5, p. 665, doi. 10.1007/s00280-012-1956-1

By:

Choi, Yoon;
Oh, Sang;
Kim, Jun;
Nam, Seung-Hyun;
Kim, Bong-Seog;
Cho, Sang-Hee;
Chung, Ik;
Song, Eun-Kee;
Yim, Chang-Yeol;
Baek, Jin;
Jeung, Hei-Cheul;
Hong, Young;
Yang, Sung;
Kang, Hye

Publication type:

Article

Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01701-9

By:

Kim, Myoung Hwa;
Lee, Jeong-Rim;
Kim, Ki-Joon;
Jun, Ji Hae;
Hwang, Hye Jeong;
Lee, Wootaek;
Nam, Seung Hyun;
Oh, Ju Eun;
Yoo, Young Chul

Publication type:

Article

Radioimmunotherapy with 131I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.

Published in:

Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 6, p. 690, doi. 10.1111/ajco.13932

By:

Jang, Yoon Jung;
Lim, Sang Moo;
Lee, Inki;
Byun, Byung Hyun;
Lim, Ilhan;
Kim, Byung Il;
Choi, Chang Woon;
Lee, Seung‐Sook;
Suh, Cheolwon;
Yoon, Dok Hyun;
Kim, Inho;
Nam, Seung‐Hyun;
Lee, Mark Hong;
Won, Jong Ho;
Kong, Jee Hyun;
Jeong, Seong Hyun;
Oh, Suk Joong;
Park, Keon Woo;
Han, Jae Joon;
Song, Moo‐Kon

Publication type:

Article

Anatomical study of the adductor canal: three-dimensional micro-computed tomography, histological, and immunofluorescence findings relevant to neural blockade.

Published in:

Korean Journal of Anesthesiology, 2023, v. 76, n. 3, p. 252, doi. 10.4097/kja.22499

By:

Shin Hyo Lee;
Hee Jung Kim;
Shin Hyung Kim;
Tae-Hyeon Cho;
Hyun-Jin Kwon;
Jehoon O;
Ju Eun Hong;
Seung Hyun Nam;
Young-Il Hwang;
Hun-Mu Yang

Publication type:

Article

Simplified analysis of lipoprotein lipase activity: Evaluation of lipasemic activity of low molecular weight heparin in rats.

Published in:

Archives of Pharmacal Research, 2012, v. 35, n. 6, p. 1107, doi. 10.1007/s12272-012-0619-4

By:

Jee, Jun-Pil;
Nam, Seung-Hyun;
Park, Youmie;
Lee, Hyo-Jong;
Park, Yohan;
Maeng, Han-Joo;
Kim, Chong-Kook

Publication type:

Article

Bortezomib and the Increased Incidence of Herpes Zoster in Patients with Multiple Myeloma.

Published in:

Clinical Lymphoma & Myeloma, 2008, v. 8, n. 4, p. 237

By:

Kim, Seok Jin;
Kim, Kihyun;
Kim, Byung Soo;
Lee, Hyo-Jin;
Kim, Hawk;
Lee, Na-Ri;
Nam, Seung-Hyun;
Kwon, Jung Hye;
Kim, Hyo Jung;
Sohn, Sang Kyun;
Won, Jong-Ho;
Lee, Jae Hoon;
Suh, Cheolwon;
Yoon, Sung-Soo;
Kim, Hye Jin;
Kim, Inho;
Do, Young-Rok;
Lee, Won-Sik;
Joo, Young-Don;
Shin, Ho Jin

Publication type:

Article

Works by Seung-Hyun Nam

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma.

Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.

Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01.

Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Tissue Type Involving the Dura.

Effect of Dose Escalation with Single Opioid, Fentanyl Matrix in Patients Not Controlling Cancer Pain: A Multicenter, Prospective, Observational Study in Korea.

A Phase II Study of Single-Agent Gemcitabine as a Second-Line Treatment in Advanced Non-Small Cell Lung Cancer.

Comparison of Medical Expenditure According to Types of Hospice Care in Patients With Terminal Cancer.

Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report.

A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatmentnaïve, high-risk essential thrombocythemia as a primary treatment.

Contribution of the Sub‐Surface to Electrocatalytic Activity in Atomically Precise La<sub>0.7</sub>Sr<sub>0.3</sub>MnO<sub>3</sub> Heterostructures.

The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.

Early Imatinib Mesylate-Induced Hepatotoxicity in Chronic Myelogenous Leukaemia.

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Repeated radioimmunotherapy with I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.

Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells.

Radioimmunotherapy with <sup>131</sup>I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.

Anatomical study of the adductor canal: three-dimensional micro-computed tomography, histological, and immunofluorescence findings relevant to neural blockade.

Simplified analysis of lipoprotein lipase activity: Evaluation of lipasemic activity of low molecular weight heparin in rats.

Bortezomib and the Increased Incidence of Herpes Zoster in Patients with Multiple Myeloma.